Literature DB >> 8922808

Erysipelas: clinical and bacteriologic spectrum and serological aspects.

B Eriksson1, C Jorup-Rönström, K Karkkonen, A C Sjöblom, S E Holm.   

Abstract

The bacteriologic, serological, and clinical characteristics of 229 patients with erysipelas diagnosed during a 2-year period at a university hospital for infectious diseases in Sweden are presented. Beta-Hemolytic streptococci were detected in 34% of these patients. Group A was the dominant serogroup, but group G streptococci were found in about half as many cases. Bacteremia was present in 5%. A serological response with antistreptolysin O (ASO) and antideoxyribonuclease B (ADNase B) was seen primarily in patients harboring group A streptococci but also in those from whom no pathogen was isolated. ASO was also found in high titers in some patients with Group G streptococcal infection. The clinical course was usually benign, with few complications, but recurrences were common (occurring in 21% of the patients). No cases of streptococcal toxic shock were seen. Culture of skin biopsy specimens had low sensitivity; Beta-hemolytic were isolated from only two of 15 patients.

Entities:  

Mesh:

Year:  1996        PMID: 8922808     DOI: 10.1093/clinids/23.5.1091

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  Risk factors for erysipelas of the leg (cellulitis): case-control study.

Authors:  A Dupuy; H Benchikhi; J C Roujeau; P Bernard; L Vaillant; O Chosidow; B Sassolas; J C Guillaume; J J Grob; S Bastuji-Garin
Journal:  BMJ       Date:  1999-06-12

2.  Diagnosis and management of cellulitis.

Authors:  Tadhg Sullivan; Eoghan de Barra
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

3.  Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study.

Authors:  Kim Ekelund; Peter Skinhøj; Jesper Madsen; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Bård Reiakvam Kittang; Nina Langeland; Steinar Skrede; Haima Mylvaganam
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

Review 5.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

6.  Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.

Authors:  Maciej Piotr Chlebicki; Choon Chiat Oh
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

7.  Evidence of streptococcal origin of acute non-necrotising cellulitis: a serological study.

Authors:  M Karppelin; T Siljander; A-M Haapala; J Aittoniemi; R Huttunen; J Kere; J Vuopio; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-18       Impact factor: 3.267

Review 8.  National Athletic Trainers' Association Position Statement: Management of Acute Skin Trauma.

Authors:  Joel W Beam; Bernadette Buckley; William R Holcomb; Mario Ciocca
Journal:  J Athl Train       Date:  2017-01-16       Impact factor: 2.860

9.  Bacterial cultures, rapid strep test, and antibiotic treatment in infected hard-to-heal ulcers in primary care.

Authors:  Rut F Oien; Nina Akesson
Journal:  Scand J Prim Health Care       Date:  2012-10-10       Impact factor: 2.581

10.  Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas.

Authors:  Athena Ferreira; Mark J Bolland; Mark G Thomas
Journal:  Infection       Date:  2016-04-16       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.